More than 100 health startups and medical associations are lobbying for permanent permission to prescribe controlled substances via telehealth, a permission that has been temporarily granted due to the pandemic-era flexibilities, The Wall Street Journal reported Nov. 25.
Read the full post on Becker's Hospital Review - Healthcare News
